Cancer

News on cancer research & diagnostics, liquid biopsy, and cancer risk testing.

HalioDx, Genecast Ink Agreement to Distribute Early-Stage Colon Cancer Test in China

HalioDx said that Chinese oncologists will gain access to its Immunoscore assay for predicting the risk of recurrence of early-stage colon cancer.

Amercian Cancer Society Philanthropic Fund BrightEdge Invests in Castle Bio

BrightEdge was founded by the American Cancer Society to invest in for-profit companies developing novel cancer therapeutics and diagnostics.

Hologic Receives CE Mark for Cytology Slide, Molecular Sample Preparation Instrument

The firm said that the new instrument, which prepares slides for cytology and aliquot samples for molecular testing, offers workflow benefits to clinical labs.

FDA Approves Expanded Use of Agilent CDx for Keytruda in Lung Cancer

The diagnostic can now be used to identify a wider range of patients with stage III or metastatic NSCLC who may benefit from first-line treatment with Keytruda.

Roche Reports Flat Q1 Diagnostics Sales

Decreased sales in the firm's centralized and point-of-care business and diabetes care business were partially offset by strong growth in the molecular diagnostics business.

Apr 16, 2019

U Michigan Researchers Develop Wearable Microfluidic Device for CTC Detection, Monitoring

Premium

Apr 16, 2019

Canaccord Initiates Coverage of Guardant Health With Buy Rating

Apr 16, 2019

Cancer Genetics Q4 Revenues Down 9 Percent

Apr 15, 2019

Todos Medical, Orot+ Ink Distribution Deal for Breast Cancer Test

Apr 12, 2019

FDA Approves Qiagen Companion Dx for Bladder Cancer Drug Balversa

Apr 12, 2019

Local Coverage Determinations Roundup: Natera, Veracyte, and Decipher

Apr 12, 2019

OncoCell Targets Cancer Prognostic Space With Phagocyte-Based Collection Technology

Premium

Apr 11, 2019

Sophia Genetics Gets CE-IVD Mark for Cancer Detection Solution

Apr 10, 2019

Georgia Tech, Emory Developing Urine-Based Dx to Guide Cancer Immunotherapies

Premium

Apr 10, 2019

Guardant Health Liquid Biopsy Test to be Covered by EviCore

Apr 09, 2019

Immunotherapy Developers, Clinical Researchers Continue to Seek New Dx Strategies

Premium

Apr 09, 2019

Myriad Submits MyChoice HRD as Companion Diagnostic for GSK's Zejula

Apr 08, 2019

Expanded Germline Panel Testing in Cancer Patients Catches Risk Variants Missed by Focused Tests

Apr 08, 2019

Deep Lens Closes $14M Series A Round to Advance Digital AI Pathology Platform

Apr 05, 2019

Siemens Healthineers, Beckman Coulter, Becton Dickinson, Others Receive FDA Clearances in March

Apr 05, 2019

Healthy Nevada Project Identifies Individuals at Risk for Disease That Are Missed by Guidelines

Apr 05, 2019

23andMe DTC Breast and Ovarian Cancer Risk Test Misses Almost 90 Percent of BRCA Mutation Carriers

Apr 05, 2019

Oncimmune Signs Portugal Distribution Deal for Lung Cancer Dx

Apr 04, 2019

Memorial Sloan Kettering Nears Approval for Liquid Biopsy Test; Describes Validation at AACR

Premium

Apr 04, 2019

Lunaphore Preparing Commercial Launch of IHC Microfluidic to Speed Surgery Decisions

Premium

Featured White Papers

How to Use CrownBio's Integrated Oncology Portfolio for Target Identification and Mechanism of Action Elucidation

Immuno-Oncology: 3 Strategies for Applying Humanized Models

A Guide to Selecting Your Next Immuno-Oncology Model

Apr

23

Featured Webinar

AMP/ACMG/CAP Cancer Sequence Variant Guidelines: A Two-Year Status Report

In 2016, the Association for Molecular Pathology (AMP), in partnership with the College of American Pathologists (CAP) and American College of Molecular Genetics (ACMG), launched a set of guidelines meant to set industry standards for reporting of molecular diagnostic test results in oncology, using a tier-based system and defined levels of evidence.

Apr

24

Featured Webinar

Metabolomics Analyses to Elucidate Systemic Processes in Human Health and Disease

This webinar will provide a wide-ranging overview of the promise for metabolomics in studying human health and disease, as well as its potential for integration with other -omics disciplines.

Apr

30

Featured Webinar

Novel Methods for Improving De Novo Transcriptome Annotation with Long-Read Transcript Sequencing

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

May

08

Featured Webinar

OncoBEAM ctDNA Testing for Early Response Prediction and Therapy Surveillance in Melanoma and Pancreatic Cancer

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.

Menu

Cancer

What's Popular?

Sponsorships